Hemoteq AG
Drug Delivery Coating and Combination Products
Drug Delivery Coating and Combination Products
Hemoteq AG is a leading company in the field of contract development and manufacturing (CDMO) of special coatings for medical devices and components, focusing on drug coatings for combination products. Committed to a 360-degree approach from idea to serial production, Hemoteq reliably delivers customized solutions in coating design, product and process development, product approval, and serial production. Customers also gain access to the global expertise and resources of the Freudenberg Medical Group, making Hemoteq the hub for strategic innovations at the intersection of medical technology, pharmaceuticals, and biotechnology. Founded in 1999 and headquartered in Würselen near Aachen (Germany), Hemoteq's quality management system is certified according to ISO 13485:2016 and authorized for the Medical Device Single Audit Program (MDSAP). The last venture round investment was provided by PINOVA Capital on 01 April 2010. Hemoteq AG operates in the health care industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 1 | PINOVA Capital | 01 Apr 2010 |
| Venture Round | Unknown | 1 | Triginta Capital | 01 Jan 2002 |
| Venture Round | Unknown | 1 |
|
01 Sep 1999 |
No recent news or press coverage available for Hemoteq AG.
We care about your data, and we'd love to use cookies make your experience better.
